Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 10 February 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Sales fell below forecast because sales of equipment and consumables in the Wellness Business were below expectations, among other factors. Operating and ordinary income exceeded forecast due to factors including the reversal of valuation losses following strong product sales. Net income fell below forecast due to the recognition of an income taxes—deferred (loss) adjustment resulting from the reversal of deferred tax assets.
Provision for allowance for doubtful accounts for affiliates: ¥141 million; valuation loss on shares of affiliates: ¥50 million. These losses were recorded only in the non-consolidated financial statements and eliminated in the consolidated financial statements, and therefore have no impact on consolidated results.
| Item | Details |
|---|---|
| Net Sales | ¥2,450 million → ¥2,419 million（-1.3%） |
| Operating profit | ¥-141 million → ¥-123 million |
| Ordinary income | ¥-180 million → ¥-160 million |
| Profit attributable to owners of the parent | ¥-186 million → ¥-241 million |
| Net income per share | -123.37 yen and sen → -159.28 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 10 February 2026 |
| Previous-period results | Sales: ¥2,872 million; operating loss: ¥154 million; ordinary loss: ¥186 million; loss attributable to owners of the parent: ¥301 million; basic loss per share: ¥202.46 (fiscal year ended March 2025) |
| Reason for the revision | Sales fell below forecast because sales of equipment and consumables in the Wellness Business were below expectations, among other factors. Operating and ordinary income exceeded forecast due to factors including the reversal of valuation losses following strong product sales. Net income fell below forecast due to the recognition of an income taxes—deferred (loss) adjustment resulting from the reversal of deferred tax assets. |
| Details and amount of extraordinary loss | Provision for allowance for doubtful accounts for affiliates: ¥141 million; valuation loss on shares of affiliates: ¥50 million. These losses were recorded only in the non-consolidated financial statements and eliminated in the consolidated financial statements, and therefore have no impact on consolidated results. |
| Consolidated / non-consolidated | Consolidated/non-consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Sales fell short of forecast mainly because sales of equipment and consumables in the Wellness Business were below expectations. Operating and ordinary income exceeded forecast due to factors including the reversal of valuation losses following strong product sales, while net income fell below forecast due to the recognition of an income taxes—deferred (loss) adjustment resulting from the reversal of deferred tax assets. In the non-consolidated financial statements, the Company recorded a provision for allowance for doubtful accounts and a valuation loss on shares after taking into account the financial condition of affiliated companies and other factors.